Products

Discover nanopore sequencing

What can it do? How does it work? Our platform performance and accuracy

Explore products

Prepare Sequence Analyse
Applications
Store Resources Support About

Hanlee Ji

London Calling 2023: A single-cell approach to cancer mutation discovery and CRISPR phenotypic modelling

We developed a new single-cell approach to identify disease-related mutations from individual cells and then genome engineer these mutations into cellular experimental systems for further biological characterization. To identify mutations, we used a targeted, long-read sequencing approach on single cells to identify cancer somatic mutations and even gene fusion rearrangements. This involved leveraging nanopore long-read sequences that covered entire transcripts of cancer genes. Next, we used CRISPR based-editor technology to introduce specific cancer mutations into single cells on a large scale. We directly engineered cancer mutations among different single cells and then determined their transcriptional phenotype with integrated nanopore long- and short-read sequencing. In summary, our work demonstrates a direct and highly scalable method for identifying, modelling, and functionally assessing cancer mutation phenotype at single-cell resolution.